There are 2934 resources available
2898 - Adjuvant immunotherapy with nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma patients with no evidence of disease (NED): A randomized, double-blind phase 2 trial (IMMUNED)
Presenter: Dirk Schadendorf
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Proffered Paper – Melanoma and other skin tumours - Invited Discussant LBA66, LBA67 and 1310O
Presenter: Bartosz Chmielowski
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Slides
Webcast
2545 - 5-year survival outcomes of the CheckMate 067 phase 3 trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma
Presenter: James Larkin
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
2804 - Combination treatment with cobimetinib (C) and atezolizumab (A) vs pembrolizumab (P) in previously untreated patients (pts) with BRAFV600 wild type (wt) advanced melanoma: primary analysis from the phase 3 IMspire170 trial
Presenter: Ana Arance
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Proffered Paper – Melanoma and other skin tumours - Invited Discussant LBA68_PR, LBA69 and 1311O
Presenter: Ulrich Keilholz
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Slides
Webcast
Role of imaging follow-up
Presenter: Virginie Westeel
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Role of patient reported outcome in patients' follow-up
Presenter: Paul van Schil
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Patient perspective/expectations
Presenter: Regine Ihlen
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Thierry Berghmans
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Results of ESMO survey/collection of data regarding shortage essential medicines in Europe and beyond, along with EIU reports on specific countries
Presenter: Alexandru Eniu
Session: Essential medicines, but not always available
Resources:
Slides
Webcast